Early prediction of metastatic insulinoma using tumor size and biochemical markers: a retrospective cohort study.
文献摘要
Introduction Insulinomas are rare functional pancreatic neuroendocrine tumors. Metastasis is found in up to 15% of patients and is difficult to predict at diagnosis. Methods We retrospectively analyzed 64 patients (56.2% female, median age 49 years) with biochemically confirmed insulinoma treated at a European Neuroendocrine Tumor Society Center of Excellence between 2010 and 2024, assessing clinical characteristics, tumor biology, diagnostics, treatments and survival (median follow-up 23 months) . Results Metastasis was present in 27% of cases (17/64). Metastatic insulinomas had significantly larger primary tumors (median 32 vs. 15 mm, p Discussion Our analysis highlights relevant clinical and biological distinctions between non-metastatic and metastatic insulinomas. Based on three diagnostic parameters, we propose a predictive model for early risk stratification to guide staging intensity and follow-up in insulinoma management.